| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |